Navigation Links
Reportlinker Adds Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution: Issues, initiatives and insights for supply chain integrity
Date:11/3/2009

NEW YORK, Nov. 3 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution: Issues, initiatives and insights for supply chain integrity

http://www.reportlinker.com/p0157386/Impact-of-Counterfeits-on-Parallel-Trade--Pharmaceutical-Distribution-Issues-initiatives-and-insights-for-supply-chain-integrity.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

Introduction

Parallel trade is a legitimate method of pharmaceutical import and export within the EU zone. Although previously recognized in North America as illegal, cross-border reimportation is now permitted following legislation allowing drugs to be imported into the US from Canada. However, counterfeit drugs have been shown to be increasingly introduced into the global supply chain, which threatens patient safety, ethical pharmaceutical sales, and undermines the integrity of the distribution channels. Parallel trade is regarded as a major contributor to counterfeiting and this is explored in the report.

Furthermore, the report provides a comprehensive account of the route of market access for counterfeits and shows how companies and governments in Europe and North America are tackling the problem strategically. It also updates the reader on the latest parallel trade and anti-counterfeiting initiatives adopted globally and whether current effor
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Reportlinker Adds Contract Pharmaceutical Manufacturing, Research and Packaging
2. Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies and Markets
3. Reportlinker Adds Chinese Markets for Bladder Cancer Treatment Drugs
4. Reportlinker Adds Chinese Markets for Respiratory Drugs
5. Reportlinker Adds Driving Successful Pharma Brands: Case Studies of Real Product Launches
6. Reportlinker Adds Ion Channel Modulator Pipelines: Targets and Agents in Development
7. Reportlinker Adds Medical Devices & Equipment in India (2009)
8. Reportlinker Adds Outsourcing Preclinical Studies to China
9. Reportlinker Adds Competitor Analysis: PI3K-AKT-mTOR Inhibitors
10. Reportlinker Adds Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile
11. Reportlinker Adds Allergan Inc.: PharmaVitae Profile

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...re/--Reportlinker.comannouncesthatanewmarketresear...alDrugDelivery-USMarketTrends&Analysis http:/...ivery---US-Market-Trends--Analysis.html ,, The...ionoftherapeuticapplicationsfromthedeliveryofconve...ctherapeuticdrugs.Thefutureofthetechnologyhingeson...
(Date:11/25/2009)....25/PRNewswire/-- ChemoCentryx,Inc.,announcedtoda...T-1(theProspectiveRandomizedOralTherapyEvaluationi...patientswithmoderate-to-severeCrohn,sdiseasedemons...abilityprofile.Thestudydemonstratedevidenceofclini...dasa70-pointdecreaseintheCrohn,sDiseaseActivityInd...
(Date:11/24/2009)...Newswire-FirstCall/--Endologix,Inc.(Nasdaq: ELGX )...sorders,announcedtodaythatithasfiledamotiontostay,...tlawsuitbroughtagainstitinOctober2009byCook,Inc.Th...ianapolis,Indiana. ,, Endologixhasrequestedthat...TrademarkOffice(USPTO)conductsproceedingstore-exam...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2First Annual Conference of National Association of Healthcare Advocacy Consultants 28NAHAC 29 to Be Held Nov 14 15 3B Board of Directors Announced 59341 1First Annual Conference of National Association of Healthcare Advocacy Consultants 28NAHAC 29 to Be Held Nov 14 15 3B Board of Directors Announced 59341 2The Governator and the Disintegrator 3A A Sharp Match Holding Pharmaceutical Companies Accountable 5416 1The Governator and the Disintegrator 3A A Sharp Match Holding Pharmaceutical Companies Accountable 5416 2The Governator and the Disintegrator 3A A Sharp Match Holding Pharmaceutical Companies Accountable 5416 3Vivacare Delivers Medication Information to Patients through Doctor Websites 59336 1Vivacare Delivers Medication Information to Patients through Doctor Websites 59336 2Vivacare Delivers Medication Information to Patients through Doctor Websites 59336 3
...re-FirstCall/ -- Amylin,Pharmaceuticals, Inc. toda...tes drugs, BYETTA(R) (exenatide) injection and,SYM...peline,candidates will be presented at the America...fic Sessions being held in Chicago, IL,from June 2...esentation during the meeting that will be availab...
...20, 2007 - Neoprobe Corporation,(OTCBB:NEOP), a di...diovascular surgical and diagnostic products, toda...lticenter Phase 2 clinical,study of its lead clini...A-mannosyl-dextran). Lymphoseek is a proprietary,r... with handheld,gamma detection devices, such as Ne...
Other Medicine Technology:Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007 2Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007 3Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007 4Neoprobe Phase 2 Lymphoseek Trial Meets Primary Endpoint 2Neoprobe Phase 2 Lymphoseek Trial Meets Primary Endpoint 3
(Date:11/27/2009)...ed medical, economic burdens, study predicts , ...umber of people with diabetes in the United States...ew study predicts. , That would bring the total...ease, up from 23.7 million today. , , At the sam...will triple, the study also warns, rising from an ...
(Date:11/27/2009)...ealth™ announced today that Spectrum Health ...d Enterprise orthopedic templating solution and it... (PRWEB) November 27, 2009 -- Voyant...h (Grand Rapids, Michigan) has licensed its Trauma...its TraumaCad Extend workflow solution, to allow i...
(Date:11/27/2009)...st manufacturers who use medical load cells at the...llars by bringing in technology partner Flintec ea...ro-active medical manufacturers are calling in Fli...ir projects, ensuring that progress will not be co...lly outdated technology. , ...
(Date:11/26/2009)...--Withcoldandfluseasonuponus,it,smoreimportantthan...tionsandavoidillness. ,, "Weneedtobeproactiveno...illnessifwe,resick,"saidEileenFinerty,RN,MS,CIC(ce...ctioncontrolandoccupationalhealthatHospitalforSpec...alSurgeryhasoneofthelowestinfectionratesofanyhospi...
(Date:11/26/2009)... of Americans living with diabetes will nearly dou...million in 2034. Over the same period, spending on...lion to $336 billion, even with no increase in the...niversity of Chicago report in the December issue ...iabetes covered by Medicare will rise from 8.2 mil...
Breaking Medicine News(10 mins):Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
...en with heart failure and men with treated prostat...y denied heart transplantation. // Now, under new...and issued today by the International Society for ...nce to get a new heart,” says Stuart Russell, M.D....
...uffering today could be a result of your great-gra...uring pregnancy – and you may already have passed ...nclusion reached by researchers at Washington Stat...ts, to develop adult-onset illnesses such as cance...
...Pratapsingh Rane has backed down from his earlier ...y before marriage and not compulsory. // "We...luntary for the couple to go for the HIV/AIDS test...sm map... HIV/AIDS is linked to the tourism." he a...
...University of Aberdeen in the UK say in a new stud... to increased risk of asthma in kids//. The study ... team showed that low vitamin E in mothers was lin...'s risk of asthma, persistent wheeze, wheezing or ...
...ral drug used to reduce the amount of sugar (gluco...es, says a study.// Type 2 diabetes occurs w...t respond to it properly. Insulin is the essential...pe 2 diabetes. The disease is mainly confined to p...
...ersity of North Carolina Wilmington announce the c...aled Florida red tide brevetoxins and ultimately//...onmental Health Sciences awarded UNCW the five-yea...s west coast. "Preliminary studies with red ...
Other Medicine News:Health News:Now, Even Older Adults and Some Cancer Patients can go for Heart Transplantation 2Health News:Environmental Toxin Causes Heritable Adult-Onset Diseases 2Health News:Environmental Toxin Causes Heritable Adult-Onset Diseases 3Health News:"Beach to Bedside" Study Focuses on Effects of Inhaled Toxins 2
Steel Knife with box, D-Profile
...k that is revolutionary, a feel that is marvelous,...ll please the most demanding of users. Based on y...g new ground with an innovative design the SureCut...r laboratory cutting and sectioning needs.,NE...
Feather Disposable Blades, Pack of 50
SureCut M3500 Fine Thread Conversion Kit
Medicine Products: